Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 5A (eIF5A) is a highly conserved, essential protein that functions primarily as an elongation factor during protein synthesis. It promotes translation elongation by facilitating peptide bond formation, especially at ribosomal stalls caused by certain amino acid sequences such as polyproline stretches. eIF5A also stimulates translation termination. A unique feature is the presence of hypusine, an unusual amino acid formed post-translationally from lysine and essential for its function. Germline deleterious heterozygous variants in EIF5A cause Faundes-Banka syndrome. It is also closely associated with cell proliferation and highly expressed in tumor cells, and acts as a cofactor for HIV Rev protein function.
Stabilizes peptidyl-tRNA; resolves stalled ribosomes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic Translation Initiation Factor 5A (eIF5A).